Results 91 to 100 of about 23,148 (170)

Targeting Inflammation by Pioglitazone and its R-Enantiomer Mitigates Pathological Myocardial Remodeling in Murine Hypertrophic Cardiomyopathy. [PDF]

JACC Basic Transl Sci
Pfaller AT, Veneziano C, Murthi SR, Stöckl JB, Shashikadze B, Flenkenthaler F, Gorham J, Moretti A, Kitanovic A, Gearing LJ, Heinrich F, Durek P, Lehmann K, Mashreghi MF, Ewert P, Fröhlich T, Schmitt JP, Spielmann N, Hrabě de Angelis M, Schmid M, Toepfer CN, Latz E, Klingel K, Santamaria G, Seidman JG, Seidman CE, Wolf CM.   +26 more
europepmc   +1 more source

The Role of Antidiabetic Therapies in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review of Metformin, Pioglitazone, and GLP-1 Receptor Agonists. [PDF]

Int J Mol Sci
Mahoon DA, Hamad O, Butler AE.
europepmc   +1 more source

Differential Effects of Oral Antidiabetic Drugs on Skeletal Muscle Mass and Hemoglobin Levels in Adults with Type 2 Diabetes Mellitus: A Prospective Real-World Cohort Study. [PDF]

J Clin Med
Ziyadanoğlu FP, Çiftçi Öztürk E, Şengün G, Şahin Sİ, Aydın BÇ, Ataoğlu HE.   +5 more
europepmc   +1 more source

Is there still room for pioglitazone in contemporary type 2 diabetes management? [PDF]

Cardiovasc Diabetol
Caruso I.
europepmc   +1 more source

GC-MS metabolomic profiling and PPARγ-targeted <i>in silico</i> approaches for identifying a potential anti-diabetic compound from traditional rice varieties. [PDF]

Front Nutr
Nallusamy S, Vanitha K, Riswana Begam M, Sathyamoorthy NK, Geetha P, Parveen S, Akhansha J, Senbagavalli G, Kokilavani S.   +8 more
europepmc   +1 more source

Modulatory effects of Pioglitazone on the CAF-driven malignant phenotype in cervical cancer: an in vitro bidirectional study. [PDF]

Discov Oncol
Díaz-Palomera CD, González-Lucano LR, García-Bernal JR, de Arellano-Sánchez JAR, Villegas-Pineda JC, Villegas-Pacheco R, Jave-Suárez LF, Pereira-Suárez AL.   +7 more
europepmc   +1 more source

Pioglitazone Attenuates Sepsis-Associated Acute Kidney Injury by Modulating TLR-4/NF-κB Signaling and Improving Survival and Renal Function. [PDF]

J Clin Med
Hacım NA, Akbaş A, Akbaş B, Ercan G, Serdaroglu A, Aygun H, Erbas O.   +6 more
europepmc   +1 more source

PPAR-γ agonist Inactivate Cellular Senescence by Inhibiting SIRT1 Signaling to Confer Increased Sensitivity to Olaparib in Ovarian Cancer Cells. [PDF]

Saudi J Med Med Sci
Wang Z, Miao W, Gao J, Zhang X.
europepmc   +1 more source

Effects of Zaozhu Yinchen Decoction on a Rat Model of Nonalcoholic Steatohepatitis via Regulation of Myeloid-Derived Suppressor Cells. [PDF]

Hepat Med
Zhang W, Wang Y, Liu Y, Zheng X, Wang T, Kwan X, Liu R, Liu Q, Zhuang H, Liang H, Chen S.   +10 more
europepmc   +1 more source

Modifying muscle metabolic dysregulation in inclusion body myositis with pioglitazone: a single-arm trial. [PDF]

Nat Commun
Adler BL, Bene MR, Zhang C, Say C, Khare P, Mecoli C, Tiniakou E, Paik JJ, Chung T, Darrah E, Lloyd T, Pagkatipunan R, McGowan M, Mears A, Vernon HJ, Christopher-Stine L, Le A, Albayda J.   +17 more
europepmc   +1 more source